Abivax Sa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abivax Sa with three other
miscellaneous service companies in Europe:
Mologen AG
of Germany
(2014
sales of 12,000.00 Euro [US$13,245.00 ]
of which 100%
was Goods & Services),
Silence Therapeutics Plc
of the United Kingdom
(£15,000.00 [US$19,633.50 ]
of which 100%
was RNA therapeutics), and
Quantum Genomics SA
(12,000.00 Euro [US$13,245.00 ]
).
Sales Analysis.